Wed May 25, 2022 – 6:14 pm EDT
(LifeSiteNews) — Public Services and Procurement Canada put out a tender for 500,000 smallpox vaccines doses that can be used against monkeypox weeks before the first cases were reported.
A report from Public Services and Procurement Canada shows that 500,000 doses of “a third generation” smallpox vaccine called Imvamune were ordered “on behalf of the Public Health Agency of Canada (PHAC)” on April 21, weeks before the first cases of monkeypox were reported to the World Health Organization on May 13.
“Although smallpox disease is currently considered to be eradicated, PHAC is procuring a stockpile of the vaccine to immunize Canadians against smallpox disease should a risk ever arise where smallpox is intentionally or unintentionally released,” the April 21 tender reads.
In the “Evaluation Criteria,” the contract states that “prior to contract award, the vaccine must have Health Canada regulatory approval for active immunization against smallpox, monkeypox and related orthopoxvirus infection and disease in adults 18 years of age and older determined to be at high risk for exposure.”
The “Term of Contract” is listed for April 1, 2023 to March 21, 2028.
The order for the shots comes despite
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors
